Comparative Assessment of Haematological Profile, CD4 Cell and Viral Load Counts of HIV-Positive Clients Attending Aminu Kano Teaching Hospital (AKTH), Kano State, Nigeria
DOI:
https://doi.org/10.47430/ujmr.2492.013Keywords:
HIV, CD4 counts, Viral load counts, Haematological profile, White blood cell counts, LymphocyteAbstract
Study’s Excerpt
- The utilization of haematological parameters as supplementary markers for monitoring HIV treatment and disease progression is assessed.
- The relationships between haematological indices and both CD4+ cell counts and viral loads is analyzed.
- These parameters could serve as alternative monitoring approaches in tracking HIV status.
Full Abstract
The cluster of differentiation-4 (CD4+) cell counts and HIV RNA concentration are the biomarkers used in treatment monitoring and HIV disease progression. However, this presents unique challenges in resource-limited settings due to limited healthcare infrastructure, financial constraints, and reduced access to diagnostic tools. This study aims to evaluate and compare the haematological parameters of HIV-positive patients and compare them with their CD4+ cell and viral load counts to ascertain their usefulness in monitoring HIV treatment and disease progression. One hundred and ninety-six (196) HIV-positive clients already on antiretroviral therapy, aged 18-75 years old, were enrolled, and their haematological parameters, Viral load, and CD4+ cell counts were evaluated. The data obtained were analyzed using descriptive statistics, one-way ANOVA, and Tukey's multiple comparison analysis. The mean (±SD) age of the study participants was 39.42 ±3.78 years. A comparison of the haematological indices of study participants based on their CD4+ cell counts reveals a significant difference between the mean of participants in stages I and II of HIV disease progression (P-value: 0.023). Also, the mean lymphocyte counts for participants in stages I and II and between those in stages II and III were significantly different (P-value: 0.0017, <0.0001, respectively). However, when participants were grouped based on their Viral load count, a significant difference was only observed for white blood cell (WBC) count between those whose viral load was below 20 copies/ml and those with above 1000 copies/ml (P-value 0.0421). Conclusively, it was observed that there is a relatively significant difference in WBC count, lymphocyte counts, and percentage lymphocyte count based on the participant's CD4+ cell and viral load count. Mild anaemia was also documented. These findings further substantiate the importance of haematological parameters in HIV treatment and disease progression monitoring.
Downloads
References
Afari, S., K. & Blay, E., A. (2018). Prevalence of Haematological and Serum Biochemical Abnormalities in HIV Infected Patients in Ghana, Before and after Antiretroviral Therapy. Interntion Journ of Virololgy and AIDS 5:039. https://doi.org/10.23937/2469-567X/1510039
Akinbami, A., Oshinaike, O., Adeyemo, T., Adediran, A., Dosunmu, O., Dada, M., Durojaiye, I., Adebola, A., & Vincent, O. (2010). Hematologic Abnormalities in Treatment-naïve HIV Patients. Infectious Diseases: Research and Treatment. https://doi.org/10.4137/IDRT.S6033
Awofala, A. A., & Ogundele, O. E. (2018). HIV epidemiology in Nigeria. Saudi journal of biological sciences, 25(4), 697–703. https://doi.org/10.1016/j.sjbs.2016.03.006
Behler, C., Shade, S., Gregory, K., Abrams, D., & Volberding, P. (2005). Anaemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS research and human retroviruses, 21(3), 200–206. https://doi.org/10.1089/aid.2005.21.200
Belperio, P. S., & Rhew, D. C. (2004). Prevalence and outcomes of anaemia in individuals with human immunodeficiency virus: A systematic review of the literature. The American Journal of Medicine, 116(7), 27-43. https://doi.org/10.1016/j.amjmed.2003.12.010
Chukwu, I., Ositadimma, M., Bright O., E., Samuel C., M. & Okechukwu, O., C. (2016). Effect of HIV Infection on Some Haematological Parameters and Immunoglobulin Levels in HIV Patients in Benin City, Southern Nigeria. Journal of HIV & Retro Virus, (2) 2:17. https://doi.org/10.21767/2471-9676.100017
Damtie, S., Workineh, L., Kiros, T., Eyayu, T., & Tiruneh, T. (2021). Hematological Abnormalities of Adult HIV-Infected Patients Before and After Initiation of Highly Active Antiretroviral Treatment at Debre Tabor Comprehensive Specialized Hospital, Northcentral Ethiopia: A Cross-Sectional Study. HIV/AIDS - Research and Palliative Care, 13: 477–484. https://doi.org/10.2147/HIV.S308422
De Santis, G. C., Brunetta, D. M., Vilar, F. C., Brandão, R. A., de Albernaz Muniz, R. Z., de Lima, G. M. N., Amorelli-Chacel, M. E., Covas, D. T., & Machado, A. A. (2011). Hematological abnormalities in HIV-infected patients. International Journal of Infectious Diseases, 15(12), 808–811. https://doi.org/10.1016/j.ijid.2011.08.001
Denue, B. A., Abja, A. U., Kida, I. M., Gabdo, A. M., Bukar, A. A., & Akawu, C. B. (2013). Evaluating Total Lymphocyte Counts and Other Hematological Parameters as a Substitute for CD4 Counts in the Management of Hiv Patients in Northeastern Nigeria. Retrovirology: Research and Treatment, 2013:5 9–16. https://doi.org/10.4137/RRT.S11562
Dikshit, B., Wanchu, A., Sachdeva, R. K., Sharma, A., & Das, R. (2009). Profile of haematological abnormalities of Indian HIV-infected individuals. BMC Blood Disorders, 9, 5. https://doi.org/10.1186/1471-2326-9-5
Enawgaw, B., Alem, M., Addis, Z., & Melku, M. (2014). Determination of haematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: A comparative cross-sectional study. BMC Hematology, 14(1), 8. https://doi.org/10.1186/2052-1839-14-8
Erhabor, O., Ejele, O. A., Nwauche, C. A., & Buseri F. I. (2005). Some Haematological Parameters in Human Immunodeficiency Virus (HIV) Infected Africans: The Nigerian Perspective. Niger Journal Medicine; 14(1):33-8. https://doi.org/10.4314/njm.v14i1.37132
Federal Ministry of Health (FMoH). (2013). National HIV & AIDS and Reproductive Health Survey 2012. NARHS Plus II.
Girum, T., Wasie, A., Lentiro, K., Muktar, E., Shumbej, T., Difer, M., Shegaze, M., & Worku, A. (2018). Gender disparity in epidemiological trend of HIV/AIDS infection and treatment in Ethiopia. Archives of Public Health, 76. https://doi.org/10.1186/s13690-018-0299-8
Global AIDS Response Progress Report. Country Progress Report. Nigeria: (GARPR). (2015). p. 9-38.
Glynn, J. R., Caraël, M., Auvert, B., Kahindo, M., Chege, J., Musonda, R., Kaona, F., Buvé, A., & Study Group on the Heterogeneity of HIV Epidemics in African Cities (2001). Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS (London, England), 15 Suppl 4, S51–S60. https://doi.org/10.1097/00002030-200108004-00006
Iyabo, B., S. (2016). Haematological Profile of Patients on Antiretroviral Therapy. Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences, (6) 2: 54-60
Joint United Nations Programs on HIV/AIDs (UNIADS). (2020). Country Progress Report – Nigeria Global AIDS Monitoring 2020. Retrieved from https://www.unaids.org/sites/default/files/country/documents/NGA_2020_countryreport .pdf on 5th May 2024.
Kusfa, I. U., Abubakar A., Muktar, H. M., Ibrahim I. N., Awwalu, S., Balogun, M.S., Shehu L., & Ahmadu I. (2017). Comparative analysis of some haematological and immunological parameters of HIV-positive patients at a tertiary HIV treatment centre in Zaria, Nigeria. Sub-Saharan Africa Journal of Medicine, 4:15-9. https://doi.org/10.4103/ssajm.ssajm_45_16
Mahathir M. (1997). Women at greater risk of HIV infection. Arrows for change, 3(1), 1–2.
Mbanya, D., Assah, F., Ndembi, N., & Kaptue, L. (2006). Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts? International Journal of Infectious Diseases, 11, (2): 157-160 https://doi.org/10.1016/j.ijid.2006.02.008.
National Agency for the Control of AIDS (NACA). (2019). Nigeria Prevalence Rate. NACA Nigeria. [online] Naca.gov.ng. retrieved from https://www.naca.gov.ng/nigeria-prevalence-rate/, Accessed 18th January 2022.
National Institute of Allergy and Infectious Disease (NIAID). (2022). Disease and Condition: HIV/AIDS. Retrieved from https://www.niaid.nih.gov/diseases-conditions/hivaids, accessed on 30th March 2022.
Nigeria National HIV Surveillance Report. (2024). Retrieved from https://www.phis3project.org.ng/phis3-resources/nigeria-national-hiv-surveillance-report-january-2024/ on 22 August 2024.
Okoroiwu, H. U., Umoh, E. A., Asanga, E. E., Edet, U. O., Atim-Ebim, M. R., Tangban, E. A., Mbim, E. N., Odoemena, C. A., Uno, V. K., Asuquo, J. O., Effiom-Ekaha, O. O., Dozie-Nwakile, O. C., Uchendu, I. K., Echieh, C. P., Emmanuel, K. J., Ejemot-Nwadiaro, R. I., Nja, G. M. E., Oreh, A., Uchenwa, M. O., Ufornwa, E. C., … Povedano-Montero, F. J. (2022). Thirty-five years (1986-2021) of HIV/AIDS in Nigeria: bibliometric and scoping analysis. AIDS research and therapy, 19(1), 64. https://doi.org/10.1186/s12981-022-00489-6
Parinitha, S., & Kulkarni, M. (2012). Haematological changes in HIV infection with correlation to CD4 cell count. The Australasian Medical Journal, 5(3), 157–162. https://doi.org/10.4066/AMJ.20121008
Patwardhan, M. S, Golwilkar A. S, Abhyankar J. R, & Atre, M. C. (2002). Hematological profile of HIV positive patients. Indian Journal of Pathological Microbiology, 45 (2): 147–150.
Sabin, C. A., Griffioen, A., Yee, T. T., Emery, V. C., Martinez, E. M., Phillips A. N., et al. (2002). Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. Lancet, 360 1546-51. https://doi.org/10.1016/S0140-6736(02)11519-4
Seyoum, M., Enawgaw, B., Getaneh, Z., Engidaye, G., Asrie, F. & Melku, M. (2018). Basic Coagulation Parameters among Human Immunodeficiency Virus-Infected Adults in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study. Hindawi BioMed Research International, Volume 2018, Article ID 5320827, 9 pages https://doi.org/10.1155/2018/5320827.
Vanisri, H. R., & Vadiraja, N. (2016). Haematological outline in HIV infection in relation to CD4 cell count, a hospital based study. Indian Journal of Pathology and Oncology, April-June 2016; 3(2); 260-263. https://doi.org/10.1016/S0140-6736(02)11519-4
Vanker, N., & Ipp, H. (2014). The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 104(1), 45–48. https://doi.org/10.7196/samj.6983.
Volberding, P. (2002). The impact of anaemia on quality of life in human immunodeficiency virus-infected patients. Journal of Infectious Disease. 2002, 185: https://doi.org/10.1086/340198
WHO approved draft treatment guidelines for HIV-infected people in resource limited settings. In: The Hopkin's HIV report. The John Hopkins University AIDS Service 2002;14:1–4. Available at: http://www.hopkins-aids.edu.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rahamat I Ishaq, Aliyu Dutsinma Usman, M Bashir
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
